Infoscience

Journal article

Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice

Rationale: Daily rifapentine plus isoniazid-pyrazinamide in mice infected with Mycobacterium tuberculosis produces cure in 3 months. Whether cure corresponds to latent infection contained by host immunity or true tissue sterilization is unknown.

Fulltext

Related material

Contacts

EPFL authors